| Authors: |
Bruijn TVM; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Gérard AO; Department of Clinical Pharmacology, Université Côte d'Azur, University Hospital Centre of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, Université Côte d'Azur, Nice, France., Labat M; Saint Louis Régional Pharmacovigilance Centre, Clinical Investigation Centre (INSERM CIC 1427), Saint-Louis Hospital, Paris, France., Apalla Z; Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Binsbergen WV; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Koumaki D; Dermatology Department, University Hospital of Heraklion, Crete, Greece., Rivet V; Internal Medicine and Immunopathology Department, The Cancer University of Toulouse Oncopole, Toulouse University Hospital, Toulouse, France., Dezoteux F; Service de Dermatologie, Hôpital Claude-Huriez, Université de Lille, INFINITE Institute for Translational Research in Inflammation, Lille, France., Giacchero D; Oncology Departement, Centre Antoine Lacassagne, Nice, France., Ardern-Jones MR; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Heelan K; The Royal Marsden Foundation Trust, London, UK., Hirner JP; Department of Dermatology, University of Nebraska, Omaha, Nebraska, USA., Mayor A; Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Labots M; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands., Starink MV; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands., Laken CJV; Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Sibaud V; Department of Oncodermatology, Oncopole Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Elshot YS; Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. |
